{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:29:12Z","timestamp":1790980152285,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T00:00:00Z","timestamp":1567468800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.ajog.2019.07.031","type":"journal-article","created":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T02:05:55Z","timestamp":1563933955000},"page":"56.e1-56.e17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Serum HE4 and diagnosis of ovarian cancer in postmenopausal women with adnexal masses"],"prefix":"10.1016","volume":"222","author":[{"given":"Aleksandra","family":"Gentry-Maharaj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2632-1545","authenticated-orcid":false,"given":"Matthew","family":"Burnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Dilley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe","family":"Karpinskyj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Gunu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Mallett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Deeks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudha","family":"Sundar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3708-1732","authenticated-orcid":false,"given":"Usha","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2019.07.031_bib2","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.1097\/AOG.0000000000001768","article-title":"ACOG Committee on Practice B-G. Evaluation and management of adnexal masses. CVOG Practice bulletin no. 174","volume":"128","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.07.031_bib3","article-title":"SIGN 135","year":"2018","journal-title":"Management of epithelial ovarian cancer\u2014a national clinical guideline"},{"key":"10.1016\/j.ajog.2019.07.031_bib4","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/j.1471-0528.1990.tb02448.x","article-title":"A\u00a0risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer","volume":"97","author":"Jacobs","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2019.07.031_bib5","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ajog.2016.01.007","article-title":"Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis Group","volume":"214","author":"Timmerman","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.07.031_bib6","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/bjc.2014.333","article-title":"Strategies to diagnose ovarian cancer: new evidence from phase 3 of the multicentre international IOTA study","volume":"111","author":"Testa","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajog.2019.07.031_bib7","doi-asserted-by":"crossref","first-page":"g5920","DOI":"10.1136\/bmj.g5920","article-title":"Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study","volume":"349","author":"Van Calster","year":"2014","journal-title":"BMJ"},{"issue":"2 Pt 1","key":"10.1016\/j.ajog.2019.07.031_bib8","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/AOG.0b013e318195ad17","article-title":"The accuracy of risk scores in predicting ovarian malignancy: a systematic review","volume":"113","author":"Geomini","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.07.031_bib9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejca.2016.01.007","article-title":"Subjective assessment versus ultrasound models to diagnose ovarian cancer: a systematic review and meta-analysis","volume":"58","author":"Meys","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ajog.2019.07.031_bib10","doi-asserted-by":"crossref","first-page":"351.e351","DOI":"10.1016\/j.ajog.2011.12.029","article-title":"Serum HE4 levels are less frequently elevated than CA125 in women with benign gynecologic disorders","volume":"206","author":"Moore","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.07.031_bib11","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ygyno.2015.06.021","article-title":"A\u00a0novel diagnostic index combining HE4, CA125 and age may improve triage of women with suspected ovarian cancer\u2014an international multicenter study in women with an ovarian mass","volume":"138","author":"Karlsen","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2019.07.031_bib12","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1080\/14737140.2017.1360138","article-title":"The role of novel biomarker HE4 in the diagnosis, prognosis and follow-up of ovarian cancer: a systematic review","volume":"17","author":"Scaletta","year":"2017","journal-title":"Exp Rev Anticancer Ther"},{"key":"10.1016\/j.ajog.2019.07.031_bib13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejogrb.2012.10.036","article-title":"Human epididymis protein 4 for differential diagnosis between benign gynecologic disease and ovarian cancer: a systematic review and meta-analysis","volume":"167","author":"Lin","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2019.07.031_bib14","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory","volume":"34","author":"Kurman","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ajog.2019.07.031_bib15","doi-asserted-by":"crossref","first-page":"a2079","DOI":"10.1136\/bmj.a2079","article-title":"Recruitment to multicentre trials\u2014lessons from UKCTOCS: descriptive study","volume":"337","author":"Menon","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2019.07.031_bib16","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0140-6736(15)01224-6","article-title":"Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial","volume":"387","author":"Jacobs","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2019.07.031_bib17","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1470-2045(09)70026-9","article-title":"Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)","volume":"10","author":"Menon","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ajog.2019.07.031_bib18","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1200\/JCO.2014.59.4945","article-title":"Risk algorithm using serial biomarker measurements doubles the number of screen-detected cancers compared with a single-threshold rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening","volume":"33","author":"Menon","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ajog.2019.07.031_bib19","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1046\/j.1469-0705.2000.00287.x","article-title":"Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) Group","volume":"16","author":"Timmerman","year":"2000","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.07.031_bib20","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/uog.12270","article-title":"Risk of epithelial ovarian cancer in asymptomatic women with ultrasound-detected ovarian masses: a prospective cohort study within the UK collaborative trial of ovarian cancer screening (UKCTOCS)","volume":"40","author":"Sharma","year":"2012","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.07.031_bib21","doi-asserted-by":"crossref","unstructured":"Rubin D. Multiple imputation for nonresponse in surveys. New York, NY: John Wiley and Sons; 1987.","DOI":"10.1002\/9780470316696"},{"key":"10.1016\/j.ajog.2019.07.031_bib22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/biomet\/80.1.27","article-title":"Bias reduction of maximum likelihood estimates","volume":"80","author":"Firth","year":"1993","journal-title":"Biometrika"},{"key":"10.1016\/j.ajog.2019.07.031_bib23","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/j.ajog.2019.07.031_bib24","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1097\/IGC.0b013e318263efa2","article-title":"Diagnostic value of serum human epididymis protein 4 (HE4) in ovarian carcinoma: a systematic review and meta-analysis","volume":"22","author":"Wu","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ajog.2019.07.031_bib25","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1097\/IGC.0000000000000192","article-title":"Accuracy of serum human epididymis protein 4 in ovarian cancer diagnosis: a systematic review and meta-analysis","volume":"24","author":"Macedo","year":"2014","journal-title":"Int J Gynecol Cancer"},{"issue":"2 Pt 1","key":"10.1016\/j.ajog.2019.07.031_bib26","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/AOG.0b013e318224fce2","article-title":"Evaluation of the diagnostic accuracy of the risk of ovarian malignancy algorithm in women with a pelvic mass","volume":"118","author":"Moore","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.07.031_bib27","doi-asserted-by":"crossref","first-page":"e010333","DOI":"10.1136\/bmjopen-2015-010333","article-title":"Refining Ovarian Cancer Test accuracy Scores (ROCkeTS): protocol for a prospective longitudinal test accuracy study to validate new risk scores in women with symptoms of suspected ovarian cancer","volume":"6","author":"Sundar","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.ajog.2019.07.031_bib28","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/bjc.2013.412","article-title":"Experience of symptoms indicative of gynaecological cancers in UK women","volume":"109","author":"Low","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajog.2019.07.031_bib29","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/aogs.12538","article-title":"Specific and unspecific gynecological alarm symptoms\u2014prevalence estimates in different age groups: a population-based study","volume":"94","author":"Balasubramaniam","year":"2015","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2019.07.031_bib30","author":"Mundi"},{"key":"10.1016\/j.ajog.2019.07.031_bib31","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/jnci\/djn326","article-title":"Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design","volume":"100","author":"Pepe","year":"2008","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ajog.2019.07.031_bib32","author":"Rawcliffe"},{"key":"10.1016\/j.ajog.2019.07.031_bib33","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1745-6215-12-61","article-title":"Impact on mortality and cancer incidence rates of using random invitation from population registers for recruitment to trials","volume":"12","author":"Burnell","year":"2011","journal-title":"Trials"},{"key":"10.1016\/j.ajog.2019.07.031_bib34","article-title":"Validation of the Performance of International Ovarian Tumor Analysis (IOTA) methods in the diagnosis of early stage ovarian cancer in a non-screening population","volume":"7","author":"Froyman","year":"2017","journal-title":"Diagnostics (Basel)"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937819309366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937819309366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:25:06Z","timestamp":1757589906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937819309366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0002937819309366"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2019.07.031","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum HE4 and diagnosis of ovarian cancer in postmenopausal women with adnexal masses","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2019.07.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}